US Cardiac Rhythm Management Devices Market - Size, Share, Segmentation, Regional Insights, Key Players & Forecast, 2026–2035

By 2035, the US Cardiac Rhythm Management (CRM) Devices Market is projected to reach approximately USD 28.94 billion, expanding at a CAGR of 6.87% during the forecast period 2026–2035. The market was valued at USD 14.82 billion in 2025, with historical analysis conducted from 2021 to 2024.

Cardiac rhythm management devices are critical technologies used in the diagnosis and treatment of cardiac arrhythmias and heart failure. These devices include pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy devices (CRT-D and CRT-P), and advanced external defibrillation systems.

The United States represents one of the largest and most technologically advanced CRM markets globally. Growth is driven by rising cardiovascular disease prevalence, an aging population, technological innovation in implantable devices, expanded remote monitoring reimbursement under CMS, and increased adoption of MRI-compatible and leadless pacing systems.

With cardiovascular diseases remaining the leading cause of death in the U.S., cardiac rhythm management continues to play a pivotal role in reducing mortality and improving long-term cardiac outcomes.

Introduction

According to the US Cardiac Rhythm Management Devices Market Report, this sector is shaped by clinical necessity, device innovation, favorable reimbursement frameworks, and strong hospital infrastructure across the United States.

More than 12 million Americans suffer from arrhythmias annually, with atrial fibrillation affecting over 6 million individuals. Additionally, approximately 6.7 million Americans live with heart failure. These conditions significantly increase risks of stroke, sudden cardiac arrest, and mortality. Cardiac rhythm management devices provide lifesaving intervention through electrical stimulation, defibrillation, and synchronized pacing.

Over the past decade, the U.S. CRM market has transitioned from conventional transvenous systems toward minimally invasive, leadless pacemakers and remotely monitored implantable systems. Advanced battery longevity, wireless telemetry, and artificial intelligence-based rhythm detection algorithms are redefining clinical workflows.

As value-based care models expand and outpatient electrophysiology programs grow, CRM device utilization is increasingly shifting toward ambulatory settings while maintaining strong hospital dominance.

Key Market Drivers: What’s Fueling the US Cardiac Rhythm Management Devices Market Growth?

• Rising Cardiovascular Disease Burden
  Cardiovascular disease accounts for nearly one in every five deaths in the United States. Aging demographics, increasing obesity rates, and sedentary lifestyles contribute to higher arrhythmia and heart failure incidence, driving CRM device demand.
• Expanding Elderly Population
  By 2035, over 78 million Americans are expected to be aged 65 and older. Older populations show significantly higher rates of bradycardia, conduction disorders, and sudden cardiac arrest, increasing pacemaker and ICD implantation volumes.
• Technological Advancements
  Leadless pacemakers, subcutaneous ICDs, MRI-compatible CRT systems, and remote monitoring capabilities enhance patient safety and convenience while improving clinical outcomes.
• Reimbursement Support
  Medicare and private insurers provide structured reimbursement for CRM device implantation, follow-ups, and remote device monitoring, encouraging provider adoption.
• Remote Monitoring & AI Integration
  Remote cardiac telemetry systems reduce hospital visits and enable proactive rhythm management. AI-assisted rhythm classification improves diagnostic precision and reduces clinician workload.

Innovation in Focus: How Manufacturers Are Raising the Bar?

The US CRM market is characterized by continuous innovation in miniaturization, battery efficiency, biocompatibility, and digital connectivity.

Leadless pacemakers eliminate lead-related complications. Subcutaneous ICDs reduce infection risks. MRI-conditional devices address imaging safety concerns. AI-driven arrhythmia detection reduces false positives and enhances predictive insights.

Cloud-based device management systems enable continuous remote monitoring. Real-time alerts allow physicians to intervene before clinical deterioration occurs.

Manufacturers are investing heavily in cybersecurity frameworks to ensure HIPAA-compliant data transmission. Integration with electronic health records (EHR) systems streamlines care coordination.

Recent Developments

Recent FDA approvals for leadless pacemakers and next-generation subcutaneous ICD systems have strengthened market growth. Remote monitoring reimbursement expansion continues to support outpatient CRM management.

Hospitals are increasingly integrating CRM data into enterprise EHR systems to support predictive analytics and population health management.

Conclusion

The US Cardiac Rhythm Management Devices Market Size & Share is poised for sustained expansion, supported by aging demographics, rising arrhythmia prevalence, technological innovation, and reimbursement stability.

With projected CAGR of 6.87% through 2035, CRM devices remain essential to reducing sudden cardiac death, managing heart failure, and improving long-term cardiac outcomes across the United States.

As innovation accelerates in leadless pacing, AI integration, and remote monitoring, the CRM market will continue evolving toward proactive, data-driven cardiac care delivery across all US regions.

• Medtronic – Leading US CRM manufacturer with extensive pacemaker and ICD portfolio.
• Abbott Laboratories – Strong presence in pacemakers, ICDs, and CRT devices.
• Boston Scientific – Advanced subcutaneous ICD and CRT technologies.
• Biotronik – Innovative MRI-compatible CRM systems in US hospitals.
• ZOLL Medical Corporation – Wearable and external defibrillator solutions.
• Philips Healthcare – AED and cardiac monitoring integration.
• GE HealthCare – Advanced cardiac imaging integration with CRM systems.
• Nihon Kohden America – External defibrillation and monitoring equipment.
• MicroPort CRM – Pacemaker and ICD solutions expanding US presence.
• Cardiac Science (ZOLL) – Automated external defibrillators.
• LivaNova – Cardiac stimulation technologies.
• Schiller Americas – Defibrillation systems.
• HeartWare (Medtronic subsidiary) – Heart failure device integration.
• Impulse Dynamics – Cardiac contractility modulation systems.
• Biotronik USA – US-based CRM distribution network.
• Baxter (Hillrom) – Patient monitoring integration.
• iRhythm Technologies – Remote cardiac monitoring expansion.
• AliveCor – Digital cardiac rhythm detection technologies.
• Preventice Solutions – Remote cardiac telemetry services.
• Sorin Group (LivaNova) – Cardiac stimulation systems.
• Medico S.p.A (US distribution) – Pacemaker technologies.
• Edwards Lifesciences – Structural heart integration impacting CRM use.

• Pacemakers (Largest Segment)
  Includes single-chamber, dual-chamber, and leadless pacemakers. Widely used for bradycardia management. Leadless systems are the fastest-growing subsegment.
• Implantable Cardioverter Defibrillators (ICDs)
  Includes transvenous and subcutaneous ICDs. Used to prevent sudden cardiac death in high-risk patients.
• Cardiac Resynchronization Therapy (CRT) Devices
  CRT-P and CRT-D devices used in heart failure patients with conduction abnormalities.
• External Defibrillators
  Includes automated external defibrillators (AEDs) and wearable defibrillators used in emergency and transitional care settings.

• Bradycardia (Dominant)
  Primary indication for pacemaker implantation.
• Tachycardia
  ICDs used for ventricular tachycardia and ventricular fibrillation.
• Heart Failure
  CRT devices significantly improve survival and quality of life.
• Atrial Fibrillation
  Increasingly monitored and managed via integrated CRM technologies.
• Others
  Includes congenital rhythm disorders and post-myocardial infarction arrhythmias.

• Hospitals (Dominant)
  Majority of device implantations occur in tertiary hospitals with electrophysiology labs.
• Cardiac Centers
  Specialized centers with high procedural volumes and advanced technology adoption.
• Ambulatory Surgical Centers
  Growing site for elective pacemaker procedures due to cost efficiency.
• Specialty Clinics
  Outpatient arrhythmia management and follow-up monitoring.

• Conventional Devices
  Standard programmable implantable systems.
• MRI-Compatible Devices
  Rapidly becoming standard of care.
• Remote Monitoring Enabled Devices (Fastest Growing)
  Support continuous data transmission and proactive management.
• AI-Integrated CRM Systems
  Emerging systems leveraging predictive analytics.

West Region (Largest Market Share)

California leads in CRM adoption due to high population density, strong electrophysiology programs, and advanced medical device ecosystems. Los Angeles, San Diego, and San Francisco host leading cardiac centers.

Washington benefits from strong digital health infrastructure and hospital modernization. Arizona’s aging population significantly drives pacemaker demand. Colorado and Oregon demonstrate steady procedural growth.

Nevada, Utah, and Alaska are expanding remote monitoring programs to improve rural cardiac care access.

Northeast Region

New York and Massachusetts are major contributors due to high concentration of academic medical centers and advanced cardiac programs.

New Jersey and Pennsylvania report strong ICD and CRT implantation rates. Connecticut maintains stable CRM adoption through hospital network expansion.

High insurance coverage and strong clinical research activity drive innovation uptake in this region.

South Region (Fastest Growing CAGR)

Texas and Florida represent the largest Southern markets due to large elderly populations and high cardiovascular disease burden.

Florida’s retirement demographics significantly increase pacemaker and CRT demand. Georgia and North Carolina show increasing electrophysiology infrastructure investment.

Tennessee and Alabama report growing outpatient implantation volumes. Rural Southern states are expanding tele-cardiology and remote CRM monitoring programs.

Midwest Region

Illinois and Ohio are major contributors with strong hospital systems.

Minnesota, home to major CRM manufacturers, benefits from innovation-driven adoption.

Michigan, Indiana, Wisconsin, and Missouri show steady procedural growth supported by integrated health systems.

Rural Midwest states are leveraging wearable defibrillators and remote device monitoring to address access challenges.

1. US Cardiac Rhythm Management Devices Market: Market Introduction & Context

1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations
1.3.4 In-House Research Databases
1.3.5 Analytical Frameworks & Forecasting Models
1.3.6 Data Validation and Final Report Publishing
1.4 Key Assumptions
1.5 Market Ecosystem Overview
1.6 Stakeholder Analysis (Device Manufacturers, Component Suppliers, Hospitals, Ambulatory Centers, Distributors, Regulatory Bodies)

(What this section provides: Introduces the study scope, research framework, validation methodology, market boundaries, and stakeholder structure to ensure transparency and analytical credibility.)

2. US Cardiac Rhythm Management Devices Market: Executive Summary

2.1 Key Insights & Market Snapshot
2.2 Analyst Viewpoint
2.3 Market Attractiveness Index

(What this section provides: Summarizes major findings, growth outlook, segment dominance, investment hotspots, and strategic takeaways.)

3. US Cardiac Rhythm Management Devices Market: Market Dynamics & Outlook

3.1 Drivers and their Impact Analysis
3.2 Restraints and their Impact Analysis
3.3 Opportunities and their Impact Analysis
3.4 Patent & Innovation Analysis (2020–2025)

(What this section provides: Evaluates major growth catalysts, barriers, regulatory drivers, technological shifts, and innovation trends shaping future expansion.)

4. US Cardiac Rhythm Management Devices Market: Market Environment & Industry Analysis

4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Substitution Risk
4.2.5 Competitive Rivalry
4.3 Pricing Trend Analysis by Region (2024–2030)
4.4 Value Chain & Supply Chain Analysis
4.5 Impact of Digitalization & Remote Monitoring
4.6 Device Innovation & Clinical Adoption Landscape
4.7 Regulatory Framework Analysis (FDA, CMS)
4.8 Import/Export & Tariff Impact
4.9 Government Initiatives
4.10 Impact of Geopolitical & Supply Chain Disruptions

(What this section provides: Offers macroeconomic, competitive, regulatory, and operational insights for informed strategic decision-making.)

5. US Cardiac Rhythm Management Devices Market – By Device Type

5.1 Overview
5.2 Segment Share Analysis, By Device Type, 2025 & 2035 (%)
5.3 Pacemakers
5.3.1 Single-Chamber Pacemakers
5.3.2 Dual-Chamber Pacemakers
5.3.3 Leadless Pacemakers
5.4 Implantable Cardioverter Defibrillators (ICDs)
5.4.1 Transvenous ICDs
5.4.2 Subcutaneous ICDs
5.5 Cardiac Resynchronization Therapy (CRT) Devices
5.5.1 CRT-P
5.5.2 CRT-D
5.6 External Defibrillators
5.6.1 Automated External Defibrillators (AEDs)
5.6.2 Wearable Cardioverter Defibrillators

(What this section provides: Breaks down revenue contribution and future growth potential by device category and technology type.)

6. US Cardiac Rhythm Management Devices Market – By Indication

6.1 Overview
6.2 Segment Share Analysis, By Indication, 2025 & 2035 (%)
6.3 Bradycardia
6.4 Tachycardia
6.5 Heart Failure
6.6 Atrial Fibrillation
6.7 Others

(What this section provides: Highlights clinical demand patterns across key cardiac conditions driving CRM adoption.)

7. US Cardiac Rhythm Management Devices Market – By End-User

7.1 Overview
7.2 Segment Share Analysis, By End-User, 2025 & 2035 (%)
7.3 Hospitals
7.4 Cardiac Centers
7.5 Ambulatory Surgical Centers
7.6 Specialty Clinics

(What this section provides: Identifies institutional demand centers and procedure volume distribution.)

8. US Cardiac Rhythm Management Devices Market – By Technology & Connectivity

8.1 Overview
8.2 Segment Share Analysis, By Technology & Connectivity, 2025 & 2035 (%)
8.3 Conventional Devices
8.4 MRI-Compatible Devices
8.5 Remote Monitoring Enabled Devices
8.6 AI-Integrated CRM Systems

(What this section provides: Explains technological differentiation and digital transformation within CRM systems.)

9. US Cardiac Rhythm Management Devices Market – By Geography

9.1 Introduction
9.2 Segment Share Analysis, By Geography, 2025 & 2035 (%)

9.3 West Region

9.3.1 Regional Overview & Trends
9.3.2 Key Manufacturers in West Region
9.3.3 Market Size and Forecast, By State, 2025–2035 (USD Million)
9.3.4 Market Size and Forecast, By Device Type
9.3.5 Market Size and Forecast, By Indication
9.3.6 Market Size and Forecast, By End-User
9.3.7 Market Size and Forecast, By Technology

9.3.8 California
9.3.9 Washington
9.3.10 Colorado
9.3.11 Arizona
9.3.12 Oregon
9.3.13 Nevada
9.3.14 Utah
9.3.15 New Mexico
9.3.16 Idaho
9.3.17 Montana
9.3.18 Wyoming
9.3.19 Alaska
9.3.20 Hawaii

9.4 Northeast Region

9.4.1 Regional Overview & Trends
9.4.2 New York
9.4.3 Massachusetts
9.4.4 New Jersey
9.4.5 Pennsylvania
9.4.6 Connecticut
9.4.7 Maine
9.4.8 Vermont
9.4.9 New Hampshire
9.4.10 Rhode Island
9.4.11 Delaware

9.5 South Region

9.5.1 Regional Overview & Trends
9.5.2 Texas
9.5.3 Florida
9.5.4 Georgia
9.5.5 North Carolina
9.5.6 Tennessee
9.5.7 South Carolina
9.5.8 Alabama
9.5.9 Mississippi
9.5.10 Louisiana
9.5.11 Arkansas
9.5.12 Kentucky
9.5.13 Oklahoma
9.5.14 Maryland
9.5.15 Virginia
9.5.16 West Virginia

9.6 Midwest Region

9.6.1 Regional Overview & Trends
9.6.2 Illinois
9.6.3 Ohio
9.6.4 Michigan
9.6.5 Minnesota
9.6.6 Indiana
9.6.7 Wisconsin
9.6.8 Missouri
9.6.9 Iowa
9.6.10 Kansas
9.6.11 Nebraska
9.6.12 North Dakota
9.6.13 South Dakota

(What this section provides: Detailed state-level revenue forecasts, regional growth trends, and investment hotspots across all 50 U.S. states.)

10. US Cardiac Rhythm Management Devices Market: Competitive Landscape & Company Profiles

10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix
10.3 Company Profiles

10.3.1 Medtronic
10.3.2 Abbott Laboratories
10.3.3 Boston Scientific
10.3.4 Biotronik
10.3.5 ZOLL Medical Corporation
10.3.6 Philips Healthcare
10.3.7 GE HealthCare
10.3.8 Nihon Kohden America
10.3.9 MicroPort CRM
10.3.10 LivaNova
10.3.11 Cardiac Science (ZOLL)
10.3.12 Schiller Americas
10.3.13 Impulse Dynamics
10.3.14 Baxter (Hillrom)
10.3.15 iRhythm Technologies
10.3.16 AliveCor
10.3.17 Preventice Solutions
10.3.18 Edwards Lifesciences
10.3.19 BIOTRONIK USA
10.3.20 Sorin Group (LivaNova)
10.3.21 Medico S.p.A (US Distribution)
10.3.22 HeartWare (Medtronic Subsidiary)

(Note: Each company profile includes Overview, Product Portfolio, Strategic Initiatives, Financial Highlights, and Recent Developments.)

(What this section provides: Competitive benchmarking, market share positioning, and strategic intelligence on leading players.)

11. US Cardiac Rhythm Management Devices Market: Future Market Outlook (2025–2035)

11.1 Scenario Analysis (Optimistic, Realistic, Pessimistic)
11.2 Disruptive Technology Impact
11.3 Emerging Clinical & Business Trends
11.4 Investment & Partnership Opportunities

(What this section provides: Forward-looking projections and potential disruption scenarios for strategic planning.)

12. US Cardiac Rhythm Management Devices Market: Strategic Recommendations

12.1 Recommendations for Manufacturers
12.2 Recommendations for Healthcare Providers
12.3 Recommendations for Investors
12.4 Market Entry & Expansion Strategies

(What this section provides: Actionable insights to maximize growth opportunities and mitigate market risks.)

13. US Cardiac Rhythm Management Devices Market: Disclaimer

(What this section provides: Legal limitations, usage boundaries, and intellectual property disclaimers associated with the study.)

List of Tables

TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: US Cardiac Rhythm Management Devices Market: Device Type Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Device Type
TABLE 6: US Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 7: US Cardiac Rhythm Management Devices Market: Indication Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Indication
TABLE 9: US Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 10: US Cardiac Rhythm Management Devices Market: End-User Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by End-User
TABLE 12: US Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 13: US Cardiac Rhythm Management Devices Market: Technology & Connectivity Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by Technology & Connectivity
TABLE 15: US Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 16: US Cardiac Rhythm Management Devices Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Region
TABLE 18: US Cardiac Rhythm Management Devices Market, by Region, 2022–2035 (USD Million)
TABLE 19: California Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 20: California Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 21: California Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 22: California Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 23: Washington Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 24: Washington Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 25: Washington Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 26: Washington Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 27: Colorado Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 28: Colorado Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 29: Colorado Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 30: Colorado Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 31: Arizona Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 32: Arizona Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 33: Arizona Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 34: Arizona Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 35: Oregon Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 36: Oregon Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 37: Oregon Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 38: Oregon Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 39: West – Others Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 40: West – Others Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 41: West – Others Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 42: West – Others Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)
TABLE 43: New York Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 44: New York Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 45: New York Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 46: New York Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 47: Massachusetts Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 48: Massachusetts Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 49: Massachusetts Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 50: Massachusetts Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 51: New Jersey Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 52: New Jersey Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 53: New Jersey Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 54: New Jersey Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 55: Pennsylvania Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 56: Pennsylvania Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 57: Pennsylvania Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 58: Pennsylvania Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 59: Connecticut Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 60: Connecticut Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 61: Connecticut Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 62: Connecticut Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 63: Northeast – Others Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 64: Northeast – Others Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 65: Northeast – Others Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 66: Northeast – Others Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)
TABLE 67: Texas Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 68: Texas Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 69: Texas Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 70: Texas Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 71: Florida Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 72: Florida Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 73: Florida Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 74: Florida Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 75: Georgia Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 76: Georgia Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 77: Georgia Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 78: Georgia Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 79: North Carolina Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 80: North Carolina Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 81: North Carolina Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 82: North Carolina Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 83: Tennessee Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 84: Tennessee Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 85: Tennessee Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 86: Tennessee Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 87: South Carolina Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 88: South Carolina Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 89: South Carolina Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 90: South Carolina Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 91: Alabama Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 92: Alabama Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 93: Alabama Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 94: Alabama Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 95: South – Others Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 96: South – Others Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 97: South – Others Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 98: South – Others Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia)
TABLE 99: Illinois Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 100: Illinois Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 101: Illinois Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 102: Illinois Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 103: Ohio Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 104: Ohio Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 105: Ohio Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 106: Ohio Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 107: Michigan Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 108: Michigan Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 109: Michigan Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 110: Michigan Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 111: Minnesota Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 112: Minnesota Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 113: Minnesota Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 114: Minnesota Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 115: Indiana Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 116: Indiana Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 117: Indiana Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 118: Indiana Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 119: Wisconsin Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 120: Wisconsin Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 121: Wisconsin Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 122: Wisconsin Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 123: Missouri Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 124: Missouri Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 125: Missouri Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 126: Missouri Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 127: Midwest – Others Cardiac Rhythm Management Devices Market, by Device Type, 2022–2035 (USD Million)
TABLE 128: Midwest – Others Cardiac Rhythm Management Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 129: Midwest – Others Cardiac Rhythm Management Devices Market, by Technology & Connectivity, 2022–2035 (USD Million)
TABLE 130: Midwest – Others Cardiac Rhythm Management Devices Market, by End-User, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)

List of Figures

FIGURE 1: US Cardiac Rhythm Management Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTLE Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2024)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Device Type Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Device Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 12: Indication Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Indication Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 14: End-User Segment Market Share Analysis, 2025 & 2035
FIGURE 15: End-User Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 16: Technology & Connectivity Segment Market Share Analysis, 2025 & 2035
FIGURE 17: Technology & Connectivity Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 20: West Region US Cardiac Rhythm Management Devices Market Share and Leading Players, 2025
FIGURE 21: Northeast Region US Cardiac Rhythm Management Devices Market Share and Leading Players, 2025
FIGURE 22: South Region US Cardiac Rhythm Management Devices Market Share and Leading Players, 2025
FIGURE 23: Midwest Region US Cardiac Rhythm Management Devices Market Share and Leading Players, 2025
FIGURE 24: West Region Market Share Analysis by State, 2025
FIGURE 25: California Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 26: Washington Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 27: Colorado Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 28: Arizona Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 29: Oregon Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 30: Others (West Region) Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2025
FIGURE 32: Texas Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 33: Florida Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 34: Georgia Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 35: North Carolina Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 36: Tennessee Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 37: South Carolina Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 38: Alabama Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 39: Others (South Region) Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2025
FIGURE 41: Illinois Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 42: Ohio Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 43: Michigan Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 44: Minnesota Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 45: Indiana Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 46: Wisconsin Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 47: Missouri Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 48: Others (Midwest Region) Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2025
FIGURE 50: New York Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 51: Massachusetts Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 52: New Jersey Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 53: Pennsylvania Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 54: Connecticut Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 55: Others (Northeast Region) Cardiac Rhythm Management Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)